Jack Stover
Founder bei NORTHVIEW ACQUISITION CORPORATION
Vermögen: 133 $ am 30.04.2024
Profil
Jack E.
Stover founded Quadrant Pharmaceuticals LLC in 2013, where he worked as President & Director and NorthView Acquisition Corp.
in 2021, where he is working as Chief Executive Officer & Director from 2021.
Mr. Stover also currently works at Traws Pharma, Inc., as Independent Director from 2016.
Mr. Stover also formerly worked at Antares Pharma, Inc., as President, Chief Executive Officer & Director from 2004 to 2008, Interpace Biosciences, Inc., as President, Chief Executive Officer & Director from 2015 to 2020, Zebec Therapeutics LLC, as Chief Executive Officer from 2014 to 2015, Targeted Nano Therapeutics LLC, as Executive Chairman from 2009 to 2012, Arbios Systems, Inc., as Director from 2005 to 2008, Influmedix, Inc., as Director from 2010 to 2011, Cernostics, Inc., as Director from 2015 to 2016, Viatar CTC Solutions, Inc., as Director in 2016, B.
Braun Medical, Inc., as Director & Senior Vice President, Gynetics, Inc., as Director & Executive Vice President, PharmaCyte Biotech, Inc., as Independent Director in 2022, PDI, Inc., as Director from 2005 to 2015, SICOR, Inc., as Chief Financial Officer & Executive Vice President, PricewaterhouseCoopers LLP, as Partner, and Coopers & Lybrand LLP, as Partner.
Mr. Stover received his undergraduate degree from Lehigh University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
TRAWS PHARMA, INC.
0,00% | 10.08.2023 | 210 ( 0,00% ) | 133 $ | 30.04.2024 |
Aktive Positionen von Jack Stover
| Unternehmen | Position | Beginn |
|---|---|---|
| TRAWS PHARMA, INC. | Director/Board Member | 23.05.2016 |
| NORTHVIEW ACQUISITION CORPORATION | Founder | 19.04.2021 |
Ehemalige bekannte Positionen von Jack Stover
| Unternehmen | Position | Ende |
|---|---|---|
| PHARMACYTE BIOTECH, INC. | Director/Board Member | 01.11.2022 |
| INTERPACE BIOSCIENCES, INC. | Chief Executive Officer | 01.12.2020 |
| VIATAR CTC SOLUTIONS INC. | Director/Board Member | 01.12.2016 |
Cernostics, Inc.
 Cernostics, Inc. Medical SpecialtiesHealth Technology Cernostics, Inc. develops and commercializes cancer diagnostic tests. Its technology is based on a systems approach to evaluating tissues via anatomic pathology and simultaneously evaluates immune, stromal, stem cell and tumor biomarkers on a single slide while preserving tissue structure. The company was founded in 2008 by Michel Nederlof and Rebecca Critchley-Thorne and is headquartered in Pittsburgh, PA. | Director/Board Member | 01.07.2016 |
Ausbildung von Jack Stover
| Lehigh University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 4 |
|---|---|
| INTERPACE BIOSCIENCES, INC. | Health Technology |
| TRAWS PHARMA, INC. | Health Technology |
| NORTHVIEW ACQUISITION CORPORATION | Finance |
| PHARMACYTE BIOTECH, INC. | Health Technology |
| Private Unternehmen | 8 |
|---|---|
Antares Pharma, Inc.
 Antares Pharma, Inc. Pharmaceuticals: MajorHealth Technology Antares Pharma, Inc. is a specialty pharmaceutical company, which engages in the development and commercialization of pharmaceutical products and technologies in targeted therapeutic areas. Its products include XYOSTED injection, OTREXUP injection for subcutaneous use, and Sumatriptan injection. The company was founded in February 1979 and is headquartered in Ewing, NJ. | Health Technology |
SICOR, Inc.
 SICOR, Inc. Pharmaceuticals: MajorHealth Technology Part of Teva Pharmaceutical Industries Ltd., SICOR, Inc. is a private company that manufactures pharmaceuticals. The company is based in San Diego, CA. The company was founded by Harry E. Gruber, Jack W. Reich, Paul K. Laikind, Robert L. Engler. SICOR was acquired by Teva Pharmaceutical Industries Ltd. on January 22, 2004 for $3,297.10 million. | Health Technology |
Arbios Systems, Inc.
 Arbios Systems, Inc. Medical SpecialtiesHealth Technology Arbios Systems, Inc. engages in the development, manufacture, and marketing of liver assist therapies for medical treatment of liver failure. The company was founded by Achilles A. Demetriou and Jacek Rozga in February 1999 and is headquartered in Allendale, NJ. | Health Technology |
PricewaterhouseCoopers LLP
 PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers LLC provides assurance, tax and advisory services. Its services include audit and assurance, consulting, deals, human resources, legal, tax, and family business. The firm also offers accountability, risk management, structuring, mergers and acquisitions, and performance and process improvement. The company was founded in 1998 and is headquartered in Buffalo, NY. | Commercial Services |
B. Braun Medical, Inc.
 B. Braun Medical, Inc. Medical/Nursing ServicesHealth Services B. Braun Medical, Inc. develops, manufactures, and markets medical products and services. It offers infusion therapy, regional anesthesia and pain management, urinary care, nutrition therapy, renal therapies, ostomy care, and wound management. The company was founded in 1957 and is headquartered in Bethlehem, PA. | Health Services |
Viatar CTC Solutions, Inc.
 Viatar CTC Solutions, Inc. Medical SpecialtiesHealth Technology Viatar CTC Solutions, Inc. is a medical technology company, which engages in the treatment of patients with metastatic cancer. Its products include Viatar Therapeutic Oncopheresis System that removes circulating tumor cells from whole blood using label-free cross-flow filtration. The company was founded by Ilan K. Reich on December 18, 2007 and is headquartered in Lowell, MA. | Health Technology |
Cernostics, Inc.
Cernostics, Inc. Medical SpecialtiesHealth Technology Cernostics, Inc. develops and commercializes cancer diagnostic tests. Its technology is based on a systems approach to evaluating tissues via anatomic pathology and simultaneously evaluates immune, stromal, stem cell and tumor biomarkers on a single slide while preserving tissue structure. The company was founded in 2008 by Michel Nederlof and Rebecca Critchley-Thorne and is headquartered in Pittsburgh, PA. | Health Technology |
| Coopers & Lybrand LLP | Commercial Services |
